Q2 2022 Holdings
Filed 2022-08-15 | 72 holdings | $30.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Da32 Life Scnce TEC Acqstn C | CLASS A COM | 23312M106 | $485 | 50,000 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $726 | 825,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $833 | 240,000 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $923 | 13,275 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $1.0K | 69,200 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $1.1K | $1,950,000 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $1.3K | 453,660 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.3K | 22,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $1.5K | 88,000 | 0.0% |
| Pepgen Inc(PEPG) | COM | 713317105 | $1.7K | 175,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $1.9K | 1,644,500 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $2.1K | 136,182 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $2.1K | 252,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.3K | 75,000 | 0.0% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $3.1K | 655,404 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $3.2K | 302,226 | 0.0% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $3.3K | 592,417 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.5K | 47,236 | 0.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $3.6K | 55,222 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $3.8K | 196,018 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $3.8K | 154,400 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $3.9K | 490,000 | 0.0% |
| Inmode LTD(INMD) | SHS | M5425M103 | $4.2K | 187,449 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $4.3K | 78,400 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $4.4K | 318,100 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $4.7K | 131,873 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $4.7K | 119,000 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $4.7K | 100,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $4.8K | 194,400 | 0.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $4.9K | 72,298 | 0.0% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $5.3K | 75,094 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $5.3K | 846,000 | 0.0% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $5.8K | 184,455 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $6.1K | 79,700 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $6.2K | 77,842 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $7.5K | 258,100 | 0.0% |
| Steris PLC(STE) | SHS USD | G8473T100 | $7.7K | 37,310 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $7.7K | 4,134,868 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $7.9K | 719,600 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.1K | 370,650 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $8.6K | 68,800 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $8.8K | 914,346 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $9.3K | 3,262,703 | 0.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $9.4K | 810,676 | 0.0% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $9.7K | 257,600 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $9.7K | 841,018 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $10.9K | 183,800 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.2K | 169,696 | 0.0% |
| Neuropace Inc(NPCE) | COM | 641288105 | $11.6K | 2,334,003 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $11.9K | 3,268,948 | 0.0% |